| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 06/24/2004 | WO2004052859A1 Erythropoietin production accelerator |
| 06/24/2004 | WO2004052857A1 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists |
| 06/24/2004 | WO2004052854A2 Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/24/2004 | WO2004052852A1 3-pyrrolyl urea derivatives and their use as antiviral agents |
| 06/24/2004 | WO2004052851A1 Pyrrolydin-2-one derivatives as inhibitors of thrombin and factor xa |
| 06/24/2004 | WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators |
| 06/24/2004 | WO2004052371A2 Cyclic quinoline compounds for use in mch receptor related disorders |
| 06/24/2004 | WO2004052370A2 Quinoline compounds for use in mch receptor related disorders |
| 06/24/2004 | WO2004052304A2 Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif |
| 06/24/2004 | WO2004052280A2 Anti-angiogenic compounds and their use in cancer treatment |
| 06/24/2004 | WO2004024060A3 Metalloproteinase inhibitors and intermediates for preparation thereof |
| 06/24/2004 | WO2004014309A3 Improved process for hydroxyazapirones |
| 06/24/2004 | WO2004005288A3 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 06/24/2004 | WO2003106427A3 Pyrazole and pyrrole carboxamide insecticides |
| 06/24/2004 | WO2003099221A3 Methods for using jnk inhibitors for treating or preventing disease-related wasting |
| 06/24/2004 | WO2003090690A3 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 06/24/2004 | WO2003072056A3 Intranasal administration of mc4-r agonists |
| 06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/24/2004 | WO2003024386A8 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis |
| 06/24/2004 | US20040122237 Substituted benzazoles and methods of their use as inhibitors of Raf kinase |
| 06/24/2004 | US20040122234 Growth Hormone secretagogues |
| 06/24/2004 | US20040122232 Enantioselective process |
| 06/24/2004 | US20040122227 Cyclic guanidine derivatives and their use as pesticides |
| 06/24/2004 | US20040122219 Azo compound and process of producing the same, and novel compound and process of producing azo compounds using the same |
| 06/24/2004 | US20040122074 1-[5-(4-chloro-phenyl)-1-(2-chloro-phenyl)-4-methyl-1H-pyrazol-3-yl]-2-piperidin-1-yl-ethanone,e.g. as antagonist or inverse agonists; nicotine partial agonist; an opioid antagonist; a dopaminergic agent; an attention deficit disorder agent |
| 06/24/2004 | US20040122073 E.g., 1-[[7-(aminoiminomethyl)-2-naphthalenyl]methyl]-2,5-dioxo-4-phenyl-3-(phenylmethyl)-4-imidazolidineacetamide; enzme enzyme inhibitors of the blood Factor VIIa complex; myocardial infarction; antiischemic agents; brain disorders , |
| 06/24/2004 | US20040122063 Ethylenediamine derivatives |
| 06/24/2004 | US20040122061 Inhibitors of post-amadori advanced glycation end products |
| 06/24/2004 | US20040122056 dissolving crude omeprazole in a solvent or a mixture of solvents in which omeprazole is freely soluble, and precipitating crystal form of omeprazole with a solvent in which omeprazole is poorly soluble. |
| 06/24/2004 | US20040122053 2-(substituted-phenyl)amino-imidazoline derivatives |
| 06/24/2004 | US20040122052 Isoindolin-1-one and Isoindoline-1,3-dione substituted in the 2-position with a 2,6-dioxo-3-hydroxypiperidin-5-yl group or derivative; selectively inhibit TNF alpha, useful in treating inflammation and effecting relaxation of airway smooth muscle |
| 06/24/2004 | US20040122049 heterocyclic derivatives containing N-substituted piperidine ring and an amide or urea group; useful for treating rheumatic arthritis |
| 06/24/2004 | US20040122047 Substituted tetrahydroisoquinolines |
| 06/24/2004 | US20040122046 NPY-5 antagonists |
| 06/24/2004 | US20040122038 phenanthridin derivative containing amine or amide groups; useful for treating obesity, a feeding disorder, seizures, anxiety, diabetes, hypertension, hyperlipidemia, cancer, nasal congestion, and female or male sexual dysfunction |
| 06/24/2004 | US20040122030 Substituted phthalimide and isoquinoline derivatives; thalidomide analogs that lack the piperidine-2,6-dione moiety of thalidomide |
| 06/24/2004 | US20040122026 N-[2-Methyl-3-(piperidinomethyl)phenyl]-3-[3-(3,5-dichlorobenzyl)-2-dicyanomethylidene imidazolidin-1-yl]propionamide for example; autoimmune or allergic diseases |
| 06/24/2004 | US20040122020 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity |
| 06/24/2004 | US20040122018 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives; use in combination with antineoplastic agents such as cisplatin |
| 06/24/2004 | US20040122017 Melanin concentrating hormone (MCH) modulators; metabolic and eating disorders |
| 06/24/2004 | US20040122014 Muscarinic M2 receptor antagonists; such as 4-{N-[7-(3-1-carbamoyl-1,1-diphenylmethyl)pyrrolidin-1-yl)hept-1-yl]-N-(isopropyl)amino}-1-(4-methoxypyrid-3-ylmethyl)piperidine; reduced blurred vision, constipation and dry mouth side effects |
| 06/24/2004 | US20040122009 formed via cyanuric chloride; for treatment of cancer and proliferative diseases |
| 06/24/2004 | US20040122004 such as (1R,2R)-N-[(1S)-2-amino-1-(4-fluorophenyl)-2-oxoethyl]-2-(4-{[{[ethyl(2-hydroxyethyl)amino]carbonyl}(4-fluorophenyl)amino]methyl}phenyl)cyclohexanecarboxamide; for prevention/treatment of cardiovascular disorders |
| 06/24/2004 | US20040122001 Pharmaceutical compounds |
| 06/24/2004 | US20040121998 CRF antagonistic quino- and quinazolines |
| 06/24/2004 | US20040121997 20-hydroxyeicosatetraenoic acid production inhibitors |
| 06/24/2004 | US20040121964 For prophylaxis and therapy of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases |
| 06/24/2004 | US20040121316 Method and compositions for identifying anti-HIV therapeutic compounds |
| 06/24/2004 | DE69233189T2 Heteroarylpiperidine-pyrrolidine und piperazine und ihre anwendung als antipsychotisches und analgetisches mittel Heteroarylpiperidines-pyrrolidine and piperazine and its application as an antipsychotic and analgesic medium |
| 06/24/2004 | CA2509191A1 Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/24/2004 | CA2508792A1 Heterocyclic compounds, methods of making them and their use in therapy |
| 06/24/2004 | CA2508788A1 3-pyrrolyl urea derivatives and their use as antiviral agents |
| 06/24/2004 | CA2508769A1 Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif |
| 06/24/2004 | CA2508681A1 Quinoline compounds for use in mch receptor related disorders |
| 06/24/2004 | CA2508170A1 Pyrazine-based tubulin inhibitors |
| 06/24/2004 | CA2507807A1 Process for preparing optically pure proton pump inhibitors |
| 06/24/2004 | CA2506164A1 Anthranilic acid amide derivatives and their pharmaceutical use |
| 06/24/2004 | CA2505887A1 Pyrazole and imidazole compounds and uses thereof |
| 06/23/2004 | EP1431285A1 Reverse hydroxamic acid derivatives |
| 06/23/2004 | EP1430895A1 Novel substituted benzimidazole dosage forms and method of using same |
| 06/23/2004 | EP1430120A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 06/23/2004 | EP1430102A1 Cationic reactive dyes |
| 06/23/2004 | EP1430048A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 06/23/2004 | EP1430047A1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 06/23/2004 | EP1430046A1 Process for preparing pyridyl-alkylsulfonyl pyrazole derivatives |
| 06/23/2004 | EP1430041A2 Novel sulfonic acid derivatives |
| 06/23/2004 | EP1430034A1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 06/23/2004 | EP1430033A1 Anti-inflammatory and protein kinase inhibitor composition and method of use |
| 06/23/2004 | EP1430032A2 Substituted amides for the treatment of neurological disorders |
| 06/23/2004 | EP1429773A1 Process for making substituted pyrazoles |
| 06/23/2004 | EP1429772A1 N-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl)pyrazole |
| 06/23/2004 | EP1429765A2 Inhibitors of histone deacetylase |
| 06/23/2004 | EP1429762A1 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity |
| 06/23/2004 | EP1429761A1 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 06/23/2004 | EP1429759A2 Compounds useful for treating hepatitus c virus |
| 06/23/2004 | EP1429607A1 Delta 1-pyrrolines used as pesticides |
| 06/23/2004 | EP1252157B1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 06/23/2004 | CN1507444A 2,3-diazanaphthalene derivatives with angiogenesis inhibiting activity |
| 06/23/2004 | CN1507443A Method for producing 2-azetidinone derivative |
| 06/23/2004 | CN1507436A Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers |
| 06/23/2004 | CN1507435A Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 06/23/2004 | CN1507434A Novel 4-anilinoquinoline-3-carboxamides compound |
| 06/23/2004 | CN1507432A Water-soluble dithioesters and method for polymerization thereof |
| 06/23/2004 | CN1507351A Treatment of ADHD |
| 06/23/2004 | CN1506364A Optically pure S-(-)-and R-(+)- Omeprazole prepn and the prepn process |
| 06/23/2004 | CN1506350A Process for producing N-(4-fluobenzene radical)-N-(2-hydroxy-4-chlorobenzene group) glycocoll |
| 06/23/2004 | CN1154647C Imidazonephthyridines and their use in inducing cytokine biosynthesis |
| 06/23/2004 | CN1154642C Pyranone compounds useful to treat retroviral infections |
| 06/23/2004 | CN1154641C Anti-cancer medicine 3,6-dimethyl 1,4-dihydro 1,2,4,5-tetrazine-1,4-dimethyl amides compound and preparation process thereof |
| 06/23/2004 | CN1154638C Method for control of arthropods in animals |
| 06/23/2004 | CN1154636C Process for preparnig intermediate in preparation of substd. peperidines |
| 06/23/2004 | CN1154634C 2-phenyl-substituted heterocyclic 1,3-keonols as herbicides and pesticides |
| 06/22/2004 | US6753430 Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof |
| 06/22/2004 | US6753426 Antiinflammatory agents; autoimmune disease |
| 06/22/2004 | US6753335 Delta agonists for nervous system pain |
| 06/22/2004 | US6753334 Preparing a phenyl or quinolinyl hydrazine by reducing the corresponding diazonium salt with ascorbic acid and heating; colorless product; intermediates to drugs for reducing tissue damage from ischemia or hypoxia |
| 06/22/2004 | US6753333 Arginine salt forms of s-(-)-9- fluoro-6,7-dihydro 8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1h,5h-benzo(i,j)quinolizine-2 -carboxylic acid, a process for their preparation and pharmaceutical formulations which are |
| 06/22/2004 | US6753332 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 06/22/2004 | US6753331 Heterocyclic derivatives which inhibit factor Xa |
| 06/17/2004 | WO2004050681A2 Kinase modulators |